We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

139 hedge funds and large institutions have $443M invested in Albany Molecular Research Inc in 2017 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 45 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

5% more funds holding

Funds holding: 133 → 139 (+6)

9% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

24% less capital invested

Capital invested by funds: $581M → $443M (-$137M)

98% less call options, than puts

Call options by funds: $1.15M | Put options by funds: $67.5M

Holders
139
Holders Change
+6
Holders Change %
+4.51%
% of All Funds
3.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
49
Reduced
45
Closed
11
Calls
$1.15M
Puts
$67.5M
Net Calls
-$66.3M
Net Calls Change
+$22.6M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$65.3M
2
ACM
American Capital Management
New York
+$12.7M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$11.4M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$6.9M
5
FHAM
Folger Hill Asset Management
New York
+$3.9M

Top Sellers

Rank Fund Capital Flow
1
VNIM
Vaughan Nelson Investment Management
Texas
-$39.1M
2
Natixis Advisors
Natixis Advisors
Massachusetts
-$3.61M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.43M
4
CCP
Clough Capital Partners
Massachusetts
-$3.03M
5
PIP
Permian Investment Partners
Texas
-$2.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
51
PDT Partners
New York
$1.05M +$711K +43,420 +137%
Bank of America
52
Bank of America
North Carolina
$1.04M +$885K +54,025 +267%
Invesco
53
Invesco
Georgia
$1.01M +$159K +9,708 +16%
TCIM
54
TIAA CREF Investment Management
New York
$979K -$51.3K -3,134 -4%
DTL
55
Dynamic Technology Lab
Singapore
$861K +$1.01M +61,407 New
CSC
56
Cove Street Capital
California
$842K -$983K -60,000 -50%
HK
57
Horizon Kinetics
New York
$786K – – –
BF
58
BOK Financial
Oklahoma
$746K -$5.09K -311 -0.6%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$718K -$39.3K -2,400 -4%
SO
60
STRS Ohio
Ohio
$694K +$357K +21,800 +79%
GA
61
Geneva Advisors
Illinois
$689K +$53.3K +3,254 +7%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$688K +$204K +12,478 +34%
HCM
63
Highbridge Capital Management
New York
$688K +$804K +49,103 New
Swiss National Bank
64
Swiss National Bank
Switzerland
$644K +$42.6K +2,600 +6%
TA
65
Teachers Advisors
New York
$616K +$32.3K +1,975 +5%
NIPH
66
NN Investment Partners Holdings
Netherlands
$588K -$117K -7,155 -15%
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$571K -$54.4K -3,320 -8%
FAAS
68
First Allied Advisory Services
California
$539K +$630K +38,449 New
Prudential Financial
69
Prudential Financial
New Jersey
$536K -$4.09K -250 -0.6%
LBC
70
Lawrence B. Cohen
$527K – – –
Legal & General Group
71
Legal & General Group
United Kingdom
$520K -$1.31K -80 -0.2%
Bank of Nova Scotia
72
Bank of Nova Scotia
Ontario, Canada
$516K +$51.1K +3,120 +9%
KeyBank National Association
73
KeyBank National Association
Ohio
$485K +$21.1K +1,289 +4%
HHC
74
Hutchin Hill Capital
New York
$453K +$529K +32,300 New
CS
75
Credit Suisse
Switzerland
$452K -$316K -19,317 -38%
1 2
3
4 5

AMRI Hedge Fund Activity: Q1 2017 in Review

139 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2017, worth a combined $443M — down 24% from $581M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AMRI positions and 11 closed out — a net gain of 11 holders — while 49 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock, adding an estimated $65.3M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $39.1M sold.

  • 139 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2017, up from 133 in Q4 2016.
  • Funds reported $443M of Albany Molecular Research Inc stock for Q1 2017, down 24% quarter-over-quarter.
  • 22 funds opened new Albany Molecular Research Inc positions in Q1 2017 and 11 closed out, a net change of +11 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2017 was BlackRock, an estimated $65.3M added.
  • The largest Albany Molecular Research Inc seller in Q1 2017 was Vaughan Nelson Investment Management, an estimated $39.1M sold.

Based on aggregated 13F filings for Q1 2017.